Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 19/12/2011 16092_de.jpg

    Wolfgang Rottbauer discovers zebrafish for use in cardiology

    Zebrafish is a popular model organism for many researchers around the world. Life scientists such as evolutionary biologists, neurobiologists and toxicologists frequently use the small vertebrate for their investigations. Wolfgang Rottbauer has discovered and established the zebrafish as a model organism for cardiovascular disease research. He has also made a name for himself in this field. However, Rottbauer recalls that his efforts were…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/wolfgang-rottbauer-discovers-zebrafish-for-use-in-cardiology
  • Article - 19/12/2011 16032_de.jpg

    Lenhard Rudolph prepares four biomarkers for clinical application

    Lenhard Rudolph’s biomarker quartet is extremely promising in terms of progressing medical and clinical treatment in ageing societies. The quartet - EF-1 alpha, Chi3L3, CRAMP and OP 18 – is made up of four proteins that can potentially be used as biomarkers. Specific concentrations of these molecules in human blood provide information on the biological age and renewal capacity of the tissue and organs of patients. The biomarker quartet also…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/lenhard-rudolph-prepares-four-biomarkers-for-clinical-application
  • Article - 24/10/2009 The right part of the schematic shows a nerve cell and the left the interior of a nerve cell where two gene segments are highlighted: one of these segments is Axin2, which has bound to ß-catenin after having received a Wnt signal, and is activated; the other is Brachyury which das not bind to ß-catenin.

    Molecular switches for gene expression in the embryo

    Prof. Dr. Andreas Hecht and his team at the University of Freiburg are investigating one of seven known fundamental signalling systems that are involved in almost all embryonic development processes and that determine the fate of cells. The scientists are mainly interested in gaining insights into why the same molecules initiate different genetic programmes and hence development pathways depending on the cell type where they have their effect.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/molecular-switches-for-gene-expression-in-the-embryo
  • Press release - 23/04/2010 Logo DKFZ, blue letters "DKFZ"

    International Cancer Genome Project Publishes Article in Nature

    Information obtained in the various projects of the International Cancer Genome Consortium may soon be used to the benefit of cancer patients worldwide because the data will be freely accessible and not patentable. The project thus aims to make sure that the molecular data of the various tumor types can be used as swiftly as possible for new diagnostic methods or therapies.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/international-cancer-genome-project-publishes-article-in-nature
  • Article - 18/10/2010 The figure shows two black areas next to each other. The area on the left contains spherical accumulations of green spots, the right shows squares with green spots.<br /> <br />

    A chip to support three-dimensional tissue culture

    The KITChip developed by researchers from the Karlsruhe Institute of Technology KIT improves the three-dimensional self-organisation of cells by enabling the active flow and circulation of the cell culture media. Using smart microtechnical methods the scientists are able to adapt the microenvironment of cell types to their specific requirements which leads to specific cellular behaviour and development.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/a-chip-to-support-three-dimensional-tissue-culture
  • Article - 07/06/2008

    Life-saving surgery for high-risk patients

    A new surgical repair of the aorta that obviates the necessity to open the thorax and the abdominal cavity is highly suited to high-risk patients that could not previously be operated due to concomitant diseases or previous surgery.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/life-saving-surgery-for-high-risk-patients
  • Article - 16/01/2012 The photo shows fifteen people standing in front of a building.

    Manfred Jung: drug discovery and the epigenetic code

    Prof. Dr. Manfred Jungs team at the University of Freiburg are chemical epigeneticists whose research involves the development of methods that enable them to identify and optimise new therapeutic drugs which are able to alter the epigenetic code of cancer and other cell types. The team use a perfidious worm for their research.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/manfred-jung-drug-discovery-and-the-epigenetic-code
  • Article - 15/10/2012 18361_de.jpg

    Vegetables help fend off bacteria in the intestines

    Their discovery in the human intestines came as quite a surprise up until a few years ago LTi lymphoid tissue inducer - cells were only known to be involved in the embryonic development of the immune system. A team of researchers led by Prof. Dr. Andreas Diefenbach from the University of Freiburg Medical Centre has since been able to show the protective role played by LTi cells in fortifying the intestinal wall as a reaction to nutrients found…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/vegetables-help-fend-off-bacteria-in-the-intestines
  • Press release - 21/04/2011

    Mathematical Methods for Investigating the Hepatitis C Virus

    An international research project coordinated at Heidelberg University revolves around the development of new mathematical methods for investigating the interaction between virus and host cell as exemplified by the hepatitis C virus. The integrated “PathoSys” project assembles ten research groups of virologists, systems biologists, mathematicians, computer scientists, bioinformaticians and molecular biologists from Germany, France, Cyprus,…

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/mathematical-methods-for-investigating-the-hepatitis-c-virus
  • Article - 25/04/2018 Prevalence of malaria in Africa.

    Resistance, immunity and malaria vaccination

    People who have survived a malaria infection often develop immunity to the disease. International malaria research is aimed at exploiting a person's natural immunity in order to treat malaria effectively and avoid resistance to previously effective drugs. These new approaches also raise hopes that one day countries at high risk of malaria may be able to eradicate the devastating disease.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/resistance-immunity-and-malaria-vaccination
  • Article - 19/03/2012 16668_de.jpg

    Scientists from Heidelberg study the assembly of ribosomes

    Ribosomes are highly complex cellular nano-machines that synthesize new proteins. Their structure is relatively well known. They are assembled from immature pre-ribosomes in the cell nucleus in a process that involves numerous biogenesis factors. Researchers from Heidelberg have made a major contribution to our present understanding of the structure and function of the pre-ribosomal assembly and transport processes, and the biogenesis factors…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/scientists-from-heidelberg-study-the-assembly-of-ribosomes
  • Press release - 12/10/2011 Logo DKFZ, blue letters "DKFZ"

    Autoimmune Diseases Affect Cancer Risk

    In a recently published study, scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have calculated the interrelations between autoimmune diseases and cancer of the digestive tract. They discovered that many autoimmune diseases increase the cancer risk, while others, such as rheumatism, are associated with a significantly lower bowel cancer risk. These differing impacts on cancer risk may be attributable to the…

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/autoimmune-diseases-affect-cancer-risk
  • Article - 31/03/2009 Wilfried Berg in the Freiburg Sonozentrum, standing in front of one of the ultrasound devices.

    BERG medizinische Systeme: The Sonozentrum Freiburg – more than just baby cinema

    The Freiburg-based company Berg medizinische Systeme e.K. offers ultrasound devices in the Sonozentrum Freiburg Sonography Centre which have a surprising number of different functions. Managing Director Manfred Berg and his team have a clear and passionate focus on their clients.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/berg-medizinische-systeme-the-sonozentrum-freiburg-more-than-just-baby-cinema
  • Telemedizin - 19/10/2015 User interface of a social medical application platform.

    SMARTY – a new way to treat and care for chronically ill children

    Chronic and complex diseases in children are often a heavy burden on their families. Parents naturally want their children to have the latest treatment, and children are usually treated by several specialists. This makes it rather difficult, or, at the very least, involves considerable effort to keep everyone up to date. Dr. Joachim Riethmüller from the University Children’s Hospital in Tübingen and his team of doctors are using telemedicine in…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/smarty-a-new-way-to-treat-and-care-for-chronically-ill-children
  • Article - 02/05/2016 Schematic showing immune cells recognise a hepatitis C virus.

    Hepatitis C: a new starting point for vaccine development

    With approximately 150,000 infected people in Germany, hepatitis C is a common disease for which therapies, but no vaccine, are available. Dr. Tobias Böttler from the Freiburg University Medical Center and his team are exploring the body’s immune response to the hepatitis C virus (HCV) and have found valuable information that could be used for vaccine development.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/hepatitis-c-a-new-starting-point-for-vaccine-development
  • Press release - 14/06/2010

    Substance in broccoli supports pancreatic cancer therapy

    The new cancer medication sorafenib inhibits resistant tumour stem cells in pancreatic cancer and is especially effective when combined with sulforaphane, an organic compound found in broccoli and cauliflower.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/substance-in-broccoli-supports-pancreatic-cancer-therapy
  • Press release - 05/09/2017 PET-Gerat-Uni-Tubingen.jpg

    Cell marking opens up a window into the body

    A new and particularly reliable method for marking cells can simplify research into diseases such as myocardial infarction, diabetes or Alzheimer's and reduce the use of test animals: Scientists from the University of Tübingen have developed a method by which they can target specific cell types in mice and monitor their behavior using positron emission tomography (PET). PET-based cell tracking allows scientists to observe complex life…

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/cell-marking-opens-up-a-window-into-the-body
  • Article - 29/01/2019 RNA segments shown in black/grey, which are processed by grey and blue (represented as spheres) enzyme complexes.

    Targeted RNA editing with the body’s own enzyme activity

    Completely new possibilities for research and gene therapy became available following the development of the CRISPR/Cas method for targeted modification of the genome. However, treatment with molecular scissors is not without risk as potential errors are stored in the genome forever. Scientists from Tübingen have developed an alternative method in which the intervention takes place at the RNA level using the body's own enzymes and is thus…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/targeted-rna-editing-with-the-bodys-own-enzyme-activity
  • Article - 14/02/2011 The photo shows a model of a protein.

    A molecule that enables local virus defence

    Dr. Markus Mordstein has spent the last four years as a doctoral student at the University of Freiburg investigating the previously relatively unknown interferon lambda. He has been able to show that this molecule has similar protective functions to type I interferons and he has also found that it is far more selective in terms of the site where it exerts its effect.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/a-molecule-that-enables-local-virus-defence
  • Article - 15/03/2010 10701_de.jpg

    Campaign to eradicate malaria

    After many decades, efforts to develop an effective vaccine against malaria have finally brought researchers closer to their goal. However, the goal of eradicating malaria completely can only be reached through a complex strategy, to which researchers from Heidelberg are making intensive contributions.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/campaign-to-eradicate-malaria
  • Article - 24/10/2011 15618_de.jpg

    Ascendis Pharma: transient drug conjugates

    Ascendis Pharma’s proprietary technology platform, TransCon, is a novel prodrug technology for the production of new patentable versions of drugs already on the market, which has been developed for improving the dosage form and effect in patients. A Phase II clinical study of Ascendis Pharma’s most advanced drug candidate, a PEGylated growth hormone that only needs to be administered once-weekly to growth hormone-deficient adults, has recently…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/ascendis-pharma-transient-drug-conjugates
  • Article - 03/12/2008

    Esslingen scientists to recalculate human age

    The actual age of a person not only depends on the date he or she was born. Biological age, which is far more important in determining lifespan, can so far only be estimated rather than precisely calculated. The European MARK-AGE research project is working on finding a solution to this problem. Esslingen plays a major role in this project for two reasons: the structure of the city and the company BioTeSys.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/esslingen-scientists-to-recalculate-human-age
  • Article - 04/07/2011 14640_de.jpg

    The adhesion of cells to the endothelium and to artificial surfaces

    Professor Stefan W. Schneider from the Mannheim Medical Faculty is investigating the function of the vascular endothelium and its interaction with blood and tumour cells using microfluidics methods that enable him to measure the adhesion of cells to the walls of blood vessels under physiological flow conditions. As part of an interdisciplinary project, he is investigating the characteristics of wafer-thin surfaces covered with living cells, which…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/the-adhesion-of-cells-to-the-endothelium-and-to-artificial-surfaces
  • Dossier - 13/05/2013 19501_de.jpg

    The human proteome – the next major goal

    The “Human Proteome Project”, a ten-year global initiative that is making a systematic effort to map all human proteins, has moved from the planning to the experimental stage. How significant and how effective the project will be depends on how much the resources offered are used by proteome researchers and on the data that the researchers bring into the project.

    https:////www.gesundheitsindustrie-bw.de/en/article/dossier/the-human-proteome-the-next-major-goal
  • Article - 05/06/2012 17261_de.jpg

    Max Planck Director Izaurralde honored for groundbreaking research

    Professor Dr. Elisa Izaurralde has made important contributions to the field of RNA biology in recent years. The managing director of the Max Planck Institute for Developmental Biology in Tübingen explores the complex mechanisms of cellular gene regulation. For her work on mRNA regulation she has now been honored with the prestigious Ernst Jung Prize for Medicine.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/max-planck-director-izaurralde-honored-for-groundbreaking-research

Page 5 / 6

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2021
Website address: https://www.gesundheitsindustrie-bw.de/en/search